Sourbha Dani to Obesity
This is a "connection" page, showing publications Sourbha Dani has written about Obesity.
Connection Strength
0.908
-
Ghanta SN, Lessey C, Makwana B, Ganatra S, Dani SS. Obesity and Cardiovascular-Kidney-Metabolic Health: Ethnicity-Based Risk and Clinical Considerations. Cardiol Clin. 2025 Aug; 43(3):383-401.
Score: 0.524
-
Patel H, Sheth A, Nair A, Patel B, Thakkar S, Narasimhan B, Mehta N, Azad Z, Kowlgi GN, Desimone CV, Siontis KC, Dani SS, Labedi MR, Deshmukh AJ. Long-Term Impact of GLP-1 Receptor Agonists on AF Recurrence After Ablation in Obese Patients. J Cardiovasc Electrophysiol. 2025 Aug; 36(8):1808-1816.
Score: 0.134
-
Patel R, Wadid M, Makwana B, Kumar A, Khadke S, Bhatti A, Banker A, Husami Z, Labib S, Venesy D, Fonarow G, Kosiborod M, Al-Kindi S, Bhatt DL, Dani S, Nohria A, Butler J, Ganatra S. GLP-1 Receptor Agonists Among Patients?With Overweight or Obesity,?Diabetes,?and HFpEF on SGLT2?Inhibitors. JACC Heart Fail. 2024 Nov; 12(11):1814-1826.
Score: 0.127
-
Wahadneh OA, Rahman SU, Alziadin N, Maraey A, Raju A, Al-Khalaileh A, Albarakat MM, Aziz S, Dani SS. Inpatient outcomes of transcatheter aortic valve replacement based on class of obesity. Curr Probl Cardiol. 2024 Mar; 49(3):102407.
Score: 0.122